Sign in
4/A

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001209191-23-025474

Chief Accounting Officer acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Liao Carrie Chief Accounting Officer 2023-03-14 Grant or award +75,000 101,895 D
Loading xslF345X04/doc4a.xml…